Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment

Charlotte A. Lee; Anil Dhawan; Ragai R. Mitry; Paradzai Chitongo; Simon Walker; Raquel Fernandez-Dacosta; Celine Filippi; Sharon Lehec; Valeria Iansante; Richard Smith; Emer Fitzpatrick

Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment

Charlotte A. Lee, Anil Dhawan, Ragai R. Mitry, Paradzai Chitongo, Simon Walker, Raquel Fernandez-Dacosta, Celine Filippi, Sharon Lehec, Valeria Iansante, Richard Smith, Emer Fitzpatrick

King's College London

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	172A-173A
Journal	Hepatology
Volume	64
Publication status	Published - Oct 2016

Cite this

Lee, C. A., Dhawan, A., Mitry, R. R., Chitongo, P., Walker, S., Fernandez-Dacosta, R., Filippi, C., Lehec, S., Iansante, V., Smith, R., & Fitzpatrick, E. (2016). Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment. Hepatology, 64, 172A-173A.

@article{dc8bf2d9c8154767b11112a278179e1a,

title = "Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment",

author = "Lee, {Charlotte A.} and Anil Dhawan and Mitry, {Ragai R.} and Paradzai Chitongo and Simon Walker and Raquel Fernandez-Dacosta and Celine Filippi and Sharon Lehec and Valeria Iansante and Richard Smith and Emer Fitzpatrick",

year = "2016",

month = oct,

language = "English",

volume = "64",

pages = "172A--173A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Wolters Kluwer Health",

}

Lee, CA , Dhawan, A , Mitry, RR, Chitongo, P, Walker, S , Fernandez-Dacosta, R, Filippi, C, Lehec, S , Iansante, V , Smith, R & Fitzpatrick, E 2016, 'Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment', Hepatology, vol. 64, pp. 172A-173A.

Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment. / Lee, Charlotte A.; Dhawan, Anil ; Mitry, Ragai R. et al.
In: Hepatology, Vol. 64, 10.2016, p. 172A-173A.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Thrombalexin (a cytotopic thrombin inhibitor), successfully suppresses the innate immune response in a model of hepatocyte transplantation and may be a promising approach to improving cell engraftment

AU - Lee, Charlotte A.

AU - Dhawan, Anil

AU - Mitry, Ragai R.

AU - Chitongo, Paradzai

AU - Walker, Simon

AU - Fernandez-Dacosta, Raquel

AU - Filippi, Celine

AU - Lehec, Sharon

AU - Iansante, Valeria

AU - Smith, Richard

AU - Fitzpatrick, Emer

PY - 2016/10

Y1 - 2016/10

M3 - Meeting Abstract

SN - 0270-9139

VL - 64

SP - 172A-173A

JO - Hepatology

JF - Hepatology

ER -